SCHEMBL23770643

SCHEMBL23770643

Cc1ccc(F)cc1-c1nc(N[S+]([O-])c2cccc(N3CCNCC3)n2)ccc1C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.37
CYP1A2 P05177 3/20 0.36
ABL1 P00519 1/20 0.36
CYP2C9 P11712 1/20 0.36
SOS1 Q07889 4/20 0.34
CYP2C19 P33261 1/20 0.34
HTR2C P28335 2/20 0.33
WDR5 P61964 1/20 0.33
CHEK1 O14757 2/20 0.32
BPTF Q12830 1/20 0.32
RAF1 P04049 1/20 0.32
BRAF P15056 1/20 0.32
HTR3E A5X5Y0 1/20 0.32
HTR3B O95264 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HTR3A P46098 1/20 0.32
HTR3D Q70Z44 1/20 0.32
HTR3C Q8WXA8 1/20 0.32
CDK7 P50613 1/20 0.32
HRH4 Q9H3N8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770454 0.90 PIM1 (0.34) ABL1HTR2CWDR5
SCHEMBL23770589 0.89 WDR5 (0.31) WDR5
SCHEMBL23770705 0.88 HRH3 (0.35) WDR5
SCHEMBL23770744 0.87 RAF1 (0.33) ABL1SOS1WDR5RAF1BRAF
SCHEMBL23770795 0.85 ABL1 (0.34) ABL1WDR5RAF1BRAF
SCHEMBL23770679 0.84 TTR (0.32) ABL1WDR5
SCHEMBL23770598 0.83 ADRB2 (0.43) ADRB2CYP1A2CYP2C9CYP2C19HTR2C
SCHEMBL23770622 0.83 CTSL (0.36) ADRB2SOS1HTR2CRAF1BRAF
SCHEMBL23770787 0.82 PDE10A (0.35) CYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL23770770 0.81 ADRB2 (0.38) ADRB2CYP1A2ABL1CYP2C9SOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed